Your browser doesn't support javascript.
loading
The Structured Process to Identify Fit-For-Purpose Data: A Data Feasibility Assessment Framework.
Gatto, Nicolle M; Campbell, Ulka B; Rubinstein, Emily; Jaksa, Ashley; Mattox, Pattra; Mo, Jingping; Reynolds, Robert F.
Afiliação
  • Gatto NM; Aetion, Inc., New York, New York, USA.
  • Campbell UB; Columbia Mailman School of Public Health, New York, New York, USA.
  • Rubinstein E; Tulane School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA.
  • Jaksa A; Columbia Mailman School of Public Health, New York, New York, USA.
  • Mattox P; Pfizer Inc., New York, New York, USA.
  • Mo J; Aetion, Inc., New York, New York, USA.
  • Reynolds RF; Aetion, Inc., New York, New York, USA.
Clin Pharmacol Ther ; 111(1): 122-134, 2022 01.
Article em En | MEDLINE | ID: mdl-34716990
To complement real-world evidence (RWE) guidelines, the 2019 Structured Preapproval and Postapproval Comparative study design framework to generate valid and transparent real-world Evidence (SPACE) framework elucidated a process for designing valid and transparent real-world studies. As an extension to SPACE, here, we provide a structured framework for conducting feasibility assessments-a step-by-step guide to identify decision grade, fit-for-purpose data, which complements the United States Food and Drug Administration (FDA)'s framework for a RWE program. The process was informed by our collective experience conducting systematic feasibility assessments of existing data sources for pharmacoepidemiology studies to support regulatory decisions. Used with the SPACE framework, the Structured Process to Identify Fit-For-Purpose Data (SPIFD) provides a systematic process for conducting feasibility assessments to determine if a data source is fit for decision making, helping ensure justification and transparency throughout study development, from articulation of a specific and meaningful research question to identification of fit-for-purpose data and study design.
Assuntos

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Estudos de Viabilidade / Coleta de Dados Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Temas: ECOS / Aspectos_gerais Bases de dados: MEDLINE Assunto principal: Estudos de Viabilidade / Coleta de Dados Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Pharmacol Ther Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos